Ifp Advisors, Inc Iterum Therapeutics PLC Transaction History

Ifp Advisors, Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Sep 06, 2022	BUY	$0.19 - $0.36 $1,140 - $2,160	6,000 New	6,000 $72,000
Q2 2022 Aug 12, 2022	SELL	$0.19 - $0.36 $1,140 - $2,160	-6,000 Closed	0 $0
Q1 2022 Sep 06, 2022	BUY	$0.31 - $0.45 $1,240 - $1,800	4,000 Added 200.0%	6,000 $2,000
Q2 2021 Jul 13, 2021	BUY	$0.97 - $2.39 $970 - $2,390	1,000 Added 100.0%	2,000 $5,000
Q4 2020 Jan 25, 2021	BUY	$0.46 - $1.2 $460 - $1,200	1,000 New	1,000 $1,000

145

Ticker ITRM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,233,400
Market Cap $21.2M
Description
Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and IV formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract inf...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.